MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, PLSE had -$37,303K decrease in cash & cash equivalents over the period. -$54,437K in free cash flow.

Cash Flow Overview

Change in Cash
-$37,303K
Free Cash flow
-$54,437K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-12-31
Net loss
-72,781
Depreciation
406
Amortization of intangible assets
665
Stock-based compensation
21,457
Non-cash lease expense
1,153
Loss on disposal of fixed assets
0
Accounts receivable
274
Inventory
136
Prepaid expenses and other current assets
912
Other non-current assets
14
Accounts payable
1,132
Accrued liabilities
-3,450
Lease liabilities, net
-1,368
Net cash used in operating activities
-54,122
Purchases of property and equipment
315
Purchases of intangible assets
20
Net cash used in investing activities
-335
Proceeds from issuance of common stock under employee stock purchase plan
586
Proceeds from exercises of warrants, net of issuance costs
14,081
Proceeds from exercises of stock options
2,487
Proceeds from issuance of common stock and warrants in relation to rights offering, net of issuance costs
0
Payment of deferred issuance costs in relation to at-the-market equity offering program
0
Net cash provided by financing activities
17,154
Net (decrease) increase in cash and cash equivalents
-37,303
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

PULSE BIOSCIENCES, INC. (PLSE)

PULSE BIOSCIENCES, INC. (PLSE)